Good to see them really pushing the oncology platform now.
-Notice the cash burn with the Ph3 costs is now around 20 million per year...
-They're still quoting the 30% retail share @ 6 million per month, with no mention of the hospital segment... what's the net profit on that? somewhere between 10-15 million per year?
Add to My Watchlist
What is My Watchlist?